Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)

Naomi Aronson*, Barbara L. Herwaldt, Michael Libman, Richard Pearson, Rogelio Lopez-Velez, Peter Weina, Edgar M. Carvalho, Moshe Ephros, Selma Jeronimo, Alan Magill

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

113 Scopus citations

Abstract

It is important to realize that leishmaniasis guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or special clinical situations. The IDSA and ASTMH consider adherence to these guidelines to be voluntary, with the ultimate determinations regarding their application to be made by the physician in the light of each patient's individual circumstances.

Original languageEnglish
Pages (from-to)1539-1557
JournalClinical Infectious Diseases
Volume63
Issue number12
DOIs
StatePublished - 15 Dec 2016

Keywords

  • cutaneous leishmaniasis
  • immunocompromised host
  • leishmaniasis diagnostic testing
  • mucosal leishmaniasis
  • visceral leishmaniasis

Fingerprint

Dive into the research topics of 'Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)'. Together they form a unique fingerprint.

Cite this